2023
DOI: 10.1016/j.redox.2023.102883
|View full text |Cite
|
Sign up to set email alerts
|

Sulforaphane induced NRF2 activation in obese pregnancy attenuates developmental redox imbalance and improves early-life cardiovascular function in offspring

Paraskevi-Maria Psefteli,
Jessica K. Morris,
Elisabeth Ehler
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 77 publications
0
1
0
Order By: Relevance
“…The use of therapeutic agents that raise Nrf2 during pregnancy must, of course, be used with great care. There is a large body of safety literature on using nutritional agents that raise Nrf2 during human pregnancies, agents that produce lowering defects in the fetus [278][279][280][281][282][283][284][285][286][287]. Ref.…”
mentioning
confidence: 99%
“…The use of therapeutic agents that raise Nrf2 during pregnancy must, of course, be used with great care. There is a large body of safety literature on using nutritional agents that raise Nrf2 during human pregnancies, agents that produce lowering defects in the fetus [278][279][280][281][282][283][284][285][286][287]. Ref.…”
mentioning
confidence: 99%